| 60 | A MULTICENTER PHASE III PROSPECTIVE RANDOMIZED TRIAL OF HIGH-DOSE EPIRUBICIN IN COMBINATION WITH CYCLOPHOSPHAMIDE (EC) VERSUS DOCETAXEL FOLLOWED BY EC IN NODE-POSITIVE BREAST CANCER. GOIM (GRUPPO ONCOLOGICO ITALIA MERIDIONALE) 9902 STUDY | P. Vici, M. Brandi, F. Giotta, P. Foggi, F. Schittulli, L. Di Lauro, N. Gebbia, B. Massidda, G. Filippelli, D. Giannarelli, A. Di Benedetto, M. Mottolese, G. Colucci, M. Lopez: | Ann Oncol. 2012; 5:1121-9 | 7.384 | 7.04 |
| 61 | THE EMERGING ROLE OF ALK INHIBITORS IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER | Galetta D, Rossi A, Pisconti S, Colucci G. : | Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S45-54 | 4.13 | 5.139 |
